Teva Settles Patent Litigation with Novartis

Posted on: Fri, 19 Feb 2010 00:15:28 EST

Symbols: NVS, TEVA

Feb 19, 2010 (Close-Up Media via COMTEX) --

Teva Pharmaceutical Industries has announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva's U.S. generic version of Novartis' Famvir (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages.

Teva launched its generic famciclovir tablets in the U.S. in September 2007.

In a release, the Company noted that the present agreement releases Teva for all past and future activities in connection with the U.S. marketing and sale of Teva's generic famciclovir tablets. Under the terms of the agreement, Teva will make a one-time payment to Novartis in addition to an ongoing royalty on U.S. sales of generic famciclovir.

((Comments on this story may be sent to health@closeupmedia.com))

For full details on Novartis Ag Ads (NVS) NVS. Novartis Ag Ads (NVS) has Short Term PowerRatings at TradingMarkets. Details on Novartis Ag Ads (NVS) Short Term PowerRatings is available at This Link.

For full details on Teva Pharm Ind (TEVA) TEVA. Teva Pharm Ind (TEVA) has Short Term PowerRatings at TradingMarkets. Details on Teva Pharm Ind (TEVA) Short Term PowerRatings is available at This Link.

How to Successfully Trade ETFs

Do you want to learn how to trade more successfully, more consistently... and with more confidence?

If so, then the TPS strategy is for you.

Hundreds, if not now thousands, of ETF traders successfully use the TPS trading strategy to find the best ETF trade set-ups each day to place winning trades.

What stocks and ETFs are headed up and down this week?.

The TradingMarkets Weekly Newsletter covers this in depth and gives performance information on the previous week.

UPCOMING EVENTS

Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.

Thursday September 16 12:30 PM

Hear What Kevin Haggerty Sees in the Stock Market Today!

Wednesday September 15 01:30 PM

Building High Performing Portfolios with The Machine

Monday September 13 12:00 PM

Manage Your Own Money - A FREE Workshop

* Attendance is strictly limited and are filled on a first-come, first-served basis.

1.	Focusing on Information That Improves Your Trading
2.	3 Keys to Flawless Execution
3.	This is the Mindset of a Successful Trader
4.	How I Trade: 5 Traders Discuss Their Overall Trading Strategies
5.	4 Mental Keys That Help My Trading Performance
6.	5 Keys to Dealing with Trading Fear
7.	How to Trade Shakeouts
8.	Looking Beyond Indicators
9.	3 Ways to Maximize Your Returns
10.	5 Ways to Handle The Quicksand Of Trading

Name	Symbol	PR
iShares Barclays Aggregate Bond Fund	AGG	10
Vanguard Intermediate Term Bond ETF	BIV	10
SPDR Lehman International Treasury Bond ETF	BWX	10
ProShares UltraShort MSCI Japan	EWV	10
iShares Barclays 7-10Yr Treasury Bond Fund	IEF	10
iShares Barclays MBS Bond Fund	MBB	10
Rydex Inverse 2x S&P Select Sector Health Care ETF	RHO	10
SPDR Barclays Capital Short Term Municipal Bond ETF	SHM	10
iPath S&P 500 VIX Mid-Term Futures ETN	VXZ	10
PowerShares Build America Bond	BAB	9

About TradingMarkets Advertise Contact Careers Link to Us Help Terms & Conditions Privacy Policy Return Policy Testimonials Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.